You are here

pemvidutide

Altimmune to test obesity drug for alcohol use disorder and related health conditions

MSN/Reuters

Fri, 03/14/25 - 11:40 am

alcohol use disorder

If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

Motley Fool

Sun, 06/30/24 - 09:56 pm

Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass

BioSpace

Mon, 06/24/24 - 10:18 pm

clinical trials

Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News

BioSpace

Fri, 12/1/23 - 09:46 am

clinical trials

Altimmune completes dosing in MOMENTUM trial to treat obesity

Clinical Trials Arena

Wed, 09/13/23 - 11:15 am

clinical trials

Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist

Fierce Biotech

Wed, 09/14/22 - 08:06 pm

clinical trials

Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy

Seeking Alpha

Tue, 09/28/21 - 11:14 pm

clinical trials